Company round total
Genesis Molecular AI(原Genesis Therapeutics) · Series B
$200MA portfolio financing event does not establish this investor participated.
另一联合领投为未具名美国生命科学投资者;本轮200百万美元,公告累计超过280百万美元;不将药企合作款计作融资。
A portfolio financing event does not establish this investor participated.
另一联合领投为未具名美国生命科学投资者;本轮200百万美元,公告累计超过280百万美元;不将药企合作款计作融资。